Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines

Published:2019-09 Issue:18 Volume:29 Page:2695-2699
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Asquith Christopher R.M.,Fleck Neil,Torrice Chad D.,Crona Daniel J.,Grundner Christoph,Zuercher William J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Tuberculosis

2. World Health Organization. Global Tuberculosis Report 2018 (WHO, 2018).

3. Current medical treatment for tuberculosis

4. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era

5. Kinase inhibitors: the road ahead

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Quinoline Analogues and Nanocarrier Systems: A Dual Approach to Anti-Tubercular Therapy";European Journal of Medicinal Chemistry Reports;2024-09

2. Design, synthesis, in-silico studies and apoptotic activity of novel amide enriched 2-(1H)- quinazolinone derivatives;Heliyon;2024-05

3. Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles;International Journal of Molecular Sciences;2023-03-07

4. Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform;Scientific Reports;2022-07-27

5. Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**;ChemMedChem;2022-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3